Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Research brief

Muscle epigenetic clock in ICU survivors at 5 years and long-term muscle strength

Five years after ICU discharge, former critically ill patients showed higher muscle epigenetic age than matched healthy controls, but this measure was not associated with their poor long-term muscle strength. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Former ICU patients at 5-year follow-up showed significantly higher muscle epigenetic age, epigenetic-minus-chronological-age difference and epigenetic age acceleration than controls matched for age and sex. [1]

  2. In adjusted models, higher muscle epigenetic age measures did not substantially contribute to differentially expressed muscle RNAs in former patients versus controls. [1]

  3. The muscle epigenetic clock measures were not associated with poor long-term muscle strength, and the authors call for other muscle-specific biological predictors. [1]

The source at a glance

Study type / format
Abstract of a matched observational comparison with multivariable models
Population / context
Former ICU patients at 5-year follow-up (N = 118; 97 matched) and healthy controls (N = 160; 97 matched), aged 18–89 years.
Summary based on
Study abstract
Original publication
July 1, 2026

ICU survivors versus matched controls at 5 years

The study compared skeletal muscle DNA-methylation data from former ICU patients at 5-year follow-up (N = 118) with healthy controls (N = 160), aged 18–89 years, using the MEATv2 muscle-specific epigenetic clock. For the main comparison, 97 former patients were propensity score-matched to 97 controls for age and sex. Former patients showed significantly higher muscle epigenetic age, epigenetic minus chronological age, and epigenetic age acceleration than matched controls.

Supporting source [1]

No link to altered RNA or weak muscle strength

In adjusted multivariable models, higher muscle epigenetic age, the epigenetic-minus-chronological-age difference, or epigenetic age acceleration did not substantially contribute to differentially expressed muscle RNAs in former patients compared with controls. These measures were also not associated with the poor long-term muscle strength. The authors conclude that the muscle-specific epigenetic clock did not capture the molecular changes linked to long-term muscle weakness.

Supporting source [1]

Abstract-only scope and need for other predictors

This explainer is based only on the abstract; the full text was not reviewed. The abstract reports a matched comparison of muscle DNA-methylation data and adjusted models, but does not give effect sizes, matching details beyond age and sex, or the full model structure. The authors state that other muscle-specific biological predictors of age-related physical impairment are needed. The registration is ClinicalTrials.gov: NCT00512122.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Effect sizes, matching details beyond age and sex, and full model structure are not reported in the abstract. Associations are not causes.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    Former ICU patients showed a significantly higher
  2. Finding 2 ↑

    did not substantially contribute to differentially expressed
  3. Finding 3 ↑

    was not associated with the poor long-term

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…